Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis

References

• Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999; 99:1091 - 100; http://dx.doi.org/10.1161/01.CIR.99.8.1091; PMID: 10051305
   PubMed Web of Science ®Google Scholar
• Maisch B, Ristić AD, Hufnagel G, Pankuweit S. Pathophysiology of viral myocarditis: the role of humoral immune response. Cardiovasc Pathol 2002; 11:112 - 22; http://dx.doi.org/10.1016/S1054-8807(01)00113-2; PMID: 11934603
   PubMed Web of Science ®Google Scholar
• Huber SA, Born W, O’Brien R. Dual functions of murine gammadelta cells in inflammation and autoimmunity in coxsackievirus B3-induced myocarditis: role of Vgamma1+ and Vgamma4+ cells. Microbes Infect 2005; 7:537 - 43; http://dx.doi.org/10.1016/j.micinf.2004.12.011; PMID: 15777711
   PubMed Web of Science ®Google Scholar
• Palmenberg AC. Proteolytic processing of picornaviral polyprotein. Annu Rev Microbiol 1990; 44:603 - 23; http://dx.doi.org/10.1146/annurev.mi.44.100190.003131; PMID: 2252396
   PubMed Web of Science ®Google Scholar
• Tam PE. Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease. Viral Immunol 2006; 19:133 - 46; http://dx.doi.org/10.1089/vim.2006.19.133; PMID: 16817756
   PubMed Web of Science ®Google Scholar
• Bailey JM, Tapprich WE. Structure of the 5′ nontranslated region of the coxsackievirus b3 genome: Chemical modification and comparative sequence analysis. J Virol 2007; 81:650 - 68; http://dx.doi.org/10.1128/JVI.01327-06; PMID: 17079314
   PubMed Web of Science ®Google Scholar
• Fohlman J, Pauksen K, Morein B, Bjare U, Ilbäck NG, Friman G. High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis. Scand J Infect Dis Suppl 1993; 88:103 - 8; PMID: 8390713
   PubMedGoogle Scholar
• Henke A, Wagner E, Whitton JL, Zell R, Stelzner A. Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization. J Virol 1998; 72:8327 - 31; PMID: 9733878
   PubMed Web of Science ®Google Scholar
• Henke A, Zell R, Stelzner A. DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice. Antiviral Res 2001; 49:49 - 54; http://dx.doi.org/10.1016/S0166-3542(00)00132-7; PMID: 11166860
   PubMed Web of Science ®Google Scholar
• Xu W, Shen Y, Jiang Z, Wang Y, Chu Y, Xiong S. Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection. Vaccine 2004; 22:3603 - 12; http://dx.doi.org/10.1016/j.vaccine.2004.03.033; PMID: 15315839
   PubMed Web of Science ®Google Scholar
• Dan M, Chantler JK. A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection. J Virol 2005; 79:9285 - 95; http://dx.doi.org/10.1128/JVI.79.14.9285-9295.2005; PMID: 15994822
   PubMed Web of Science ®Google Scholar
• Kim JY, Jeon ES, Lim BK, Kim SM, Chung SK, Kim JM, Park SI, Jo I, Nam JH. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge. Vaccine 2005; 23:1672 - 9; http://dx.doi.org/10.1016/j.vaccine.2004.10.008; PMID: 15705471
   PubMed Web of Science ®Google Scholar
• Henke A, Jarasch N, Martin U, Wegert J, Wildner A, Zell R, Wutzler P. Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease. Int J Med Microbiol 2008; 298:127 - 34; http://dx.doi.org/10.1016/j.ijmm.2007.08.010; PMID: 17897883
   PubMed Web of Science ®Google Scholar
• Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, Latz E, Fitzgerald KA. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 2009; 458:514 - 8; http://dx.doi.org/10.1038/nature07725; PMID: 19158675
   PubMed Web of Science ®Google Scholar
• Schattgen SA, Fitzgerald KA. The PYHIN protein family as mediators of host defenses. Immunol Rev 2011; 243:109 - 18; http://dx.doi.org/10.1111/j.1600-065X.2011.01053.x; PMID: 21884171
   PubMed Web of Science ®Google Scholar
• Roberts TL, Idris A, Dunn JA, Kelly GM, Burnton CM, Hodgson S, Hardy LL, Garceau V, Sweet MJ, Ross IL, et al. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 2009; 323:1057 - 60; http://dx.doi.org/10.1126/science.1169841; PMID: 19131592
   PubMed Web of Science ®Google Scholar
• Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 2009; 458:509 - 13; http://dx.doi.org/10.1038/nature07710; PMID: 19158676
   PubMed Web of Science ®Google Scholar
• Fernandes-Alnemri T, Yu JW, Juliana C, Solorzano L, Kang S, Wu J, Datta P, McCormick M, Huang L, McDermott E, et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 2010; 11:385 - 93; http://dx.doi.org/10.1038/ni.1859; PMID: 20351693
   PubMed Web of Science ®Google Scholar
• Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009; 27:519 - 50; http://dx.doi.org/10.1146/annurev.immunol.021908.132612; PMID: 19302047
   PubMed Web of Science ®Google Scholar
• Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010; 10:89 - 102; http://dx.doi.org/10.1038/nri2691; PMID: 20081871
   PubMed Web of Science ®Google Scholar
• Rathinam VA, Jiang Z, Waggoner SN, Sharma S, Cole LE, Waggoner L, Vanaja SK, Monks BG, Ganesan S, Latz E, et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 2010; 11:395 - 402; http://dx.doi.org/10.1038/ni.1864; PMID: 20351692
   PubMed Web of Science ®Google Scholar
• Yue Y, Xu W, Hu L, Jiang Z, Xiong S. Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle. Virology 2009; 386:438 - 47; http://dx.doi.org/10.1016/j.virol.2009.01.029; PMID: 19233446
   PubMed Web of Science ®Google Scholar
• Mora JR, Iwata M, Eksteen B, Song SY, Junt T, Senman B, Otipoby KL, Yokota A, Takeuchi H, Ricciardi-Castagnoli P, et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science 2006; 314:1157 - 60; http://dx.doi.org/10.1126/science.1132742; PMID: 17110582
   PubMed Web of Science ®Google Scholar
• Massacand JC, Kaiser P, Ernst B, Tardivel A, Bürki K, Schneider P, Harris NL. Intestinal bacteria condition dendritic cells to promote IgA production. PLoS One 2008; 3:e2588; http://dx.doi.org/10.1371/journal.pone.0002588; PMID: 18596964
   PubMed Web of Science ®Google Scholar
• Tezuka H, Ohteki T. Regulation of intestinal homeostasis by dendritic cells. Immunol Rev 2010; 234:247 - 58; http://dx.doi.org/10.1111/j.0105-2896.2009.00872.x; PMID: 20193023
   PubMed Web of Science ®Google Scholar
• Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000; 343:1388 - 98; http://dx.doi.org/10.1056/NEJM200011093431908; PMID: 11070105
   PubMed Web of Science ®Google Scholar
• Holmgren J, Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005; 11:Suppl S45 - 53; http://dx.doi.org/10.1038/nm1213; PMID: 15812489
   PubMed Web of Science ®Google Scholar
• Kumar H, Kawai T, Akira S. Pathogen recognition in the innate immune response. Biochem J 2009; 420:1 - 16; http://dx.doi.org/10.1042/BJ20090272; PMID: 19382893
   PubMed Web of Science ®Google Scholar
• Fujkuyama Y, Tokuhara D, Kataoka K, Gilbert RS, McGhee JR, Yuki Y, Kiyono H, Fujihashi K. Novel vaccine development strategies for inducing mucosal immunity. Expert Rev Vaccines 2012; 11:367 - 79; http://dx.doi.org/10.1586/erv.11.196; PMID: 22380827
   PubMed Web of Science ®Google Scholar
• Kumagai Y, Akira S. [Role of PRRs in vaccine]. Nihon Rinsho 2011; 69:1541 - 6; PMID: 21922750
   PubMedGoogle Scholar
• Olive C. Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants. Expert Rev Vaccines 2012; 11:237 - 56; http://dx.doi.org/10.1586/erv.11.189; PMID: 22309671
   PubMed Web of Science ®Google Scholar
• Lladser A, Mougiakakos D, Tufvesson H, Ligtenberg MA, Quest AF, Kiessling R, Ljungberg K. DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity. Mol Ther 2011; 19:594 - 601; http://dx.doi.org/10.1038/mt.2010.268; PMID: 21157438
   PubMed Web of Science ®Google Scholar
• Luke JM, Simon GG, Söderholm J, Errett JS, August JT, Gale M Jr., Hodgson CP, Williams JA. Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine. J Virol 2011; 85:1370 - 83; http://dx.doi.org/10.1128/JVI.01250-10; PMID: 21106745
   PubMed Web of Science ®Google Scholar
• Sasaki S, Amara RR, Yeow WS, Pitha PM, Robinson HL. Regulation of DNA-raised immune responses by cotransfected interferon regulatory factors. J Virol 2002; 76:6652 - 9; http://dx.doi.org/10.1128/JVI.76.13.6652-6659.2002; PMID: 12050378
   PubMed Web of Science ®Google Scholar
• Takeshita F, Tanaka T, Matsuda T, Tozuka M, Kobiyama K, Saha S, Matsui K, Ishii KJ, Coban C, Akira S, et al. Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity. J Virol 2006; 80:6218 - 24; http://dx.doi.org/10.1128/JVI.00121-06; PMID: 16775309
   PubMed Web of Science ®Google Scholar
• Gao H, Yue Y, Hu L, Xu W, Xiong S. A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge. Vaccine 2009; 27:5313 - 9; http://dx.doi.org/10.1016/j.vaccine.2009.06.093; PMID: 19615961
   PubMed Web of Science ®Google Scholar
• Yue Y, Xu W, Xiong S. Modulation of immunogenicity and immunoprotection of mucosal vaccine against coxsackievirus B3 by optimizing the coadministration mode of lymphotactin adjuvant. DNA Cell Biol 2012; 31:479 - 88; http://dx.doi.org/10.1089/dna.2011.1367; PMID: 21988406
   PubMed Web of Science ®Google Scholar
• Zhao F, Liu S, Zhang X, Yu J, Zeng T, Gu W, Cao X, Chen X, Wu Y. CpG adjuvant enhances the mucosal immunogenicity and efficacy of a Treponema pallidum DNA vaccine in rabbits. Hum Vaccin Immunother 2013; 9:753 - 60; http://dx.doi.org/10.4161/hv.23064; PMID: 23563515
   PubMed Web of Science ®Google Scholar
• Mao S, Sun W, Kissel T. Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev 2010; 62:12 - 27; http://dx.doi.org/10.1016/j.addr.2009.08.004; PMID: 19796660
   PubMed Web of Science ®Google Scholar
• Lee MK, Chun SK, Choi WJ, Kim JK, Choi SH, Kim A, Oungbho K, Park JS, Ahn WS, Kim CK. The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer. Biomaterials 2005; 26:2147 - 56; http://dx.doi.org/10.1016/j.biomaterials.2004.07.008; PMID: 15576190
   PubMed Web of Science ®Google Scholar
• Bowman K, Leong KW. Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomedicine 2006; 1:117 - 28; http://dx.doi.org/10.2147/nano.2006.1.2.117; PMID: 17722528
   PubMed Web of Science ®Google Scholar
• Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res 1998; 15:1326 - 31; http://dx.doi.org/10.1023/A:1011929016601; PMID: 9755881
   PubMed Web of Science ®Google Scholar
• Dodane V, Amin Khan M, Merwin JR. Effect of chitosan on epithelial permeability and structure. Int J Pharm 1999; 182:21 - 32; http://dx.doi.org/10.1016/S0378-5173(99)00030-7; PMID: 10332071
   PubMed Web of Science ®Google Scholar
• Kumar MN, Muzzarelli RA, Muzzarelli C, Sashiwa H, Domb AJ. Chitosan chemistry and pharmaceutical perspectives. Chem Rev 2004; 104:6017 - 84; http://dx.doi.org/10.1021/cr030441b; PMID: 15584695
   PubMed Web of Science ®Google Scholar
• Baldrick P. The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmacol 2010; 56:290 - 9; http://dx.doi.org/10.1016/j.yrtph.2009.09.015; PMID: 19788905
   PubMed Web of Science ®Google Scholar
• Dass CR, Choong PF. Chitosan-mediated orally delivered nucleic acids: a gutful of gene therapy. J Drug Target 2008; 16:257 - 61; http://dx.doi.org/10.1080/10611860801900801; PMID: 18446603
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang X, Kang Y, Jin H, Du X, Zhao G, Yu Y, Li J, Su B, Huang C, et al. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus. Vaccine 2008; 26:5135 - 44; http://dx.doi.org/10.1016/j.vaccine.2008.03.088; PMID: 18462848
   PubMed Web of Science ®Google Scholar
• Mantis NJ, Rol N, Corthésy B. Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol 2011; 4:603 - 11; http://dx.doi.org/10.1038/mi.2011.41; PMID: 21975936
   PubMed Web of Science ®Google Scholar
• He B, Xu W, Santini PA, Polydorides AD, Chiu A, Estrella J, Shan M, Chadburn A, Villanacci V, Plebani A, et al. Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 2007; 26:812 - 26; http://dx.doi.org/10.1016/j.immuni.2007.04.014; PMID: 17570691
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. Function of mucosa-associated lymphoid tissue in antibody formation. Immunol Invest 2010; 39:303 - 55; http://dx.doi.org/10.3109/08820131003680369; PMID: 20450282
   PubMed Web of Science ®Google Scholar
• Marinaro M, Staats HF, Hiroi T, Jackson RJ, Coste M, Boyaka PN, Okahashi N, Yamamoto M, Kiyono H, Bluethmann H, et al. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J Immunol 1995; 155:4621 - 9; PMID: 7594461
   PubMed Web of Science ®Google Scholar
• Beagley KW, Eldridge JH, Lee F, Kiyono H, Everson MP, Koopman WJ, Hirano T, Kishimoto T, McGhee JR. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med 1989; 169:2133 - 48; http://dx.doi.org/10.1084/jem.169.6.2133; PMID: 2786548
   PubMed Web of Science ®Google Scholar
• Boyaka PN, Marinaro M, Jackson RJ, Menon S, Kiyono H, Jirillo E, McGhee JR. IL-12 is an effective adjuvant for induction of mucosal immunity. J Immunol 1999; 162:122 - 8; PMID: 9886377
   PubMed Web of Science ®Google Scholar
• Henke A, Huber S, Stelzner A, Whitton JL. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J Virol 1995; 69:6720 - 8; PMID: 7474082
   PubMed Web of Science ®Google Scholar
• Rezkalla S, Kloner RA, Khatib G, Smith FE, Khatib R. Effect of metoprolol in acute coxsackievirus B3 murine myocarditis. J Am Coll Cardiol 1988; 12:412 - 4; http://dx.doi.org/10.1016/0735-1097(88)90414-7; PMID: 2839568
   PubMed Web of Science ®Google Scholar
• Capozzo AV, Ramírez K, Polo JM, Ulmer J, Barry EM, Levine MM, Pasetti MF. Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies. J Immunol 2006; 176:5671 - 81; PMID: 16622037
   PubMed Web of Science ®Google Scholar